{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:02:46Z","timestamp":1775869366431,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIHR Manchester Biomedical Centre"},{"name":"NIHR Cambridge Biomedical Centre"},{"name":"Taylor Family Foundation"},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Oxford Biomedical Center"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ijrobp.2020.06.054","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T16:39:57Z","timestamp":1597163997000},"page":"379-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development"],"prefix":"10.1016","volume":"108","author":[{"given":"David J.","family":"Thomson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue S.","family":"Yom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hina","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issam","family":"El Naqa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Ballas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soren M.","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel T.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte E.","family":"Coles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Dover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Ashleigh","family":"Guadagnolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somnath","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Rembielak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sebag-Montefiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Sher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A.","family":"Terezakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toms V.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Estes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.06.054_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000272","article-title":"Anatomy of the epidemiological literature on the 2003 SARS outbreaks in Hong Kong and Toronto: A time-stratified review","volume":"7","author":"Xing","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib5","author":"Yasinski"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib6","doi-asserted-by":"crossref","unstructured":"Filippi AR, Russi E, Magrini SM, et\u00a0al. Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreak [e-pub ahead of print]. Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.03.007. Accessed July 7,\u00a02020.","DOI":"10.1016\/j.ijrobp.2020.03.007"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ijrobp.2020.03.008","article-title":"Letter from Switzerland","volume":"107","author":"Achard","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib8","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib11","author":"Flynn"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib12","doi-asserted-by":"crossref","first-page":"m1936","DOI":"10.1136\/bmj.m1936","article-title":"Scope, quality, and inclusivity of clinical guidelines produced early in the Covid-19 pandemic: Rapid review","volume":"369","author":"Dagens","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib13","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMc2021225","article-title":"Retraction: Cardiovascular disease,\u00a0drug therapy, and mortality in Covid-19","volume":"382","author":"Mehra","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib14","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0140-6736(20)31324-6","article-title":"Retraction\u2014Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis","volume":"395","author":"Mehra","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib15","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/jama.2020.3980","article-title":"Editorial concern\u2014Possible reporting of the same patients with COVID-19 in different reports","volume":"323","author":"Bauchner","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib16","unstructured":"Tingley K. Coronavirus is forcing medical research to speed up. New York Times. 2020 2020\/04\/16\/;Sect."},{"key":"10.1016\/j.ijrobp.2020.06.054_bib17","author":"Patton"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib18","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer","volume":"35","author":"Catton","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib19","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"371","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib22","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): A multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdw062","article-title":"Long-course oxaliplatin-based preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: Results of a randomized phase III study","volume":"27","author":"Bujko","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijrobp.2005.06.014","article-title":"Radiotherapy for early glottic carcinoma (T1N0M0): Results of prospective randomized study of radiation fraction size and overall treatment time","volume":"64","author":"Yamazaki","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib26","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib27","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: The Nordic randomised, phase 3 trial","volume":"13","author":"Malmstr\u00f6m","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ijrobp.2019.08.019","article-title":"One versus three fractions of stereotactic body radiation therapy for peripheral stage I to II non-small cell lung cancer: A randomized, multi-institution, phase 2 trial","volume":"105","author":"Singh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6_suppl","key":"10.1016\/j.ijrobp.2020.06.054_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1200\/JCO.2017.35.6_suppl.280","article-title":"BC2001 long-term outcomes: A\u00a0phase III randomized trial of chemoradiotherapy versus radiotherapy (RT) alone and standard RT versus reduced high-dose volume RT in muscle-invasive bladder cancer","volume":"35","author":"Hall","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib30","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","article-title":"Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer","volume":"366","author":"James","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib31","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib33","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic body radiation therapy for localized prostate cancer: A systematic review and meta-analysis of over 6,000 patients treated on prospective studies","volume":"104","author":"Jackson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijrobp.2020.01.008","article-title":"Ten-year outcomes of moderately hypofractionated salvage postprostatectomy radiation therapy and external validation of a contemporary multivariable nomogram for biochemical failure","volume":"107","author":"Chin","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib35","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.ejca.2014.07.009","article-title":"SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III non-small cell lung cancer and good performance status","volume":"50","author":"Maguire","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1470-2045(09)70306-7","article-title":"Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK head and neck (UKHAN1) trial","volume":"11","author":"Tobias","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib37","article-title":"Four week hypofractionated accelerated intensity modulated radiotherapy and synchronous carboplatin or cetuximab in biologically staged oropharyngeal carcinoma","volume":"3","author":"Benghiat","year":"2014","journal-title":"Cancer Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canrad.2016.09.015","article-title":"Thoracic irradiation in 3 weeks for limited-stage small cell lung cancer: Is twice a day fractionation really needed?","volume":"21","author":"Turgeon","year":"2017","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib40","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdn354","article-title":"A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer","volume":"19","author":"Sculier","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib41","first-page":"55","article-title":"COVID-19: Global radiation oncology\u2019s targeted response for pandemic preparedness","volume":"22","author":"Simcock","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2020.04.016","article-title":"Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement","volume":"107","author":"Thomson","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib43","doi-asserted-by":"crossref","unstructured":"Bernhardt D, Wick W, Weiss SE, et\u00a0al. Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas [e-pub ahead of print]. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noaa113. Accessed July 10,\u00a02020.","DOI":"10.1093\/neuonc\/noaa113"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.radonc.2020.04.035","article-title":"A rapid review of evidence and recommendations from the SIOPE radiation oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises","volume":"148","author":"Janssens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib45","doi-asserted-by":"crossref","unstructured":"Al-Rashdan A, Roumeliotis M, Quirk S, et\u00a0al. Adapting radiation therapy treatments for patients with breast cancer during the COVID-19 pandemic: Hypo-fractionation and accelerated partial breast irradiation to address World Health Organization recommendations [e-pub ahead of print]. Adv Radiat Oncol. https:\/\/doi.org\/10.1016\/j.adro.2020.03.011. Accessed July 10,\u00a02020.","DOI":"10.1016\/j.adro.2020.03.011"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clon.2020.03.006","article-title":"International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic","volume":"32","author":"Coles","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib47","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib48","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): A randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib49","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: A randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejca.2017.06.014","article-title":"Preoperative breast radiation therapy: Indications and perspectives","volume":"82","author":"Lightowlers","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib53","doi-asserted-by":"crossref","unstructured":"Braunstein LZ, Gillespie EF, Hong L, et\u00a0al. Breast radiotherapy under COVID-19 pandemic resource constraints\u2014Approaches to defer or shorten treatment from a comprehensive cancer center in the United States [e-pub ahead of print]. Adv Radiat Oncol. https:\/\/doi.org\/10.1016\/j.adro.2020.03.013. Accessed July 10,\u00a02020.","DOI":"10.1016\/j.adro.2020.03.013"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib54","article-title":"Disease site-specific guidelines for curative radiation treatment during \u2018limited surgery\u2019 and \u2018hospital avoidance\u2019: A radiation oncology perspective from the epicenter of COVID-19 pandemic","volume":"12","author":"Parashar","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib55","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.radonc.2020.03.045","article-title":"Bracing for impact with new 4R\u2019s in the COVID-19 pandemic\u2014A provincial thoracic radiation oncology consensus","volume":"149","author":"Rathod","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.054_bib56","unstructured":"Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO Trial (HYPNO). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02765503. Accessed July 29, 2020."},{"key":"10.1016\/j.ijrobp.2020.06.054_bib57","unstructured":"Shorter course, hypofractionated pre-surgery radiation therapy in treating patients with localized, resectable soft tissue sarcoma of the extremity of superficial trunk. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03819985. Accessed July 29, 2020."}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620313419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620313419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:47:17Z","timestamp":1759744037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620313419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0360301620313419"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.054","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}